1-20 of 346
Ola Landgren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and efficacy of elranatamab + nirogacestat in patients with relapsed or refractory multiple myeloma: Results from the Phase 1b MagnetisMM-4 study

Free
Ola Landgren, Suzanne Trudel, Jacalyn Rosenblatt, Arleigh McCurdy, Sumit Madan, Syed Abbas Ali, Nizar Bahlis, Eli Gabayan, Robert Vescio, Melissa O'Gorman, Shinta Cheng, Sibo Jiang, Margaret Hoyle, Jay Cheng, Erik Vandendries, Noopur Raje
Journal: Blood
Blood (2025) 146 (Supplement 1): 4058.
https://doi.org/10.1182/blood-2025-4058
Published: 2025
Journal Articles

A phase 2 trial of 89Zr-DFO-daratumumab for CD38-targeted imaging of multiple myeloma (the iMMunoPET study)

Free
Ola Landgren, Russ Kuker, Ryan Reddy, Alanna Vossen, Jayashree Motwani, Ben Goldenson, Benjamin Diamond, Abhishek Pandey, James Hoffman, David Coffey, Marcella Kaddoura, Mike Georgiou, Brian Walker, Rabia Bukhari, Caterine Diaz, Stephanie Mompoint, Sindy Gutierrez, Kellye Koubek, Stephanie Fernandes, Michelle Armogan, Dickran Kazandjian, Gary Ulaner
Journal: Blood
Blood (2025) 146 (Supplement 1): 4052.
https://doi.org/10.1182/blood-2025-4052
Published: 2025
Journal Articles

Single-cell DNA sequencing uncovers synergistic co-mutations in multiple myeloma

Free
Ava Amidei, Benjamin Diamond, Elizabeth Lyubchenko, Stephanie Fernandes, Bahar Fard, Lubna Nousheen, Marc Arribas-Layton, Adam Sciambi, Dickran Kazandjian, James Hoffman, Abhishek Pandey, Marcella Kaddoura, Brian Walker, Ola Landgren, David Coffey
Journal: Blood
Blood (2025) 146 (Supplement 1): 2157.
https://doi.org/10.1182/blood-2025-2157
Published: 2025
Journal Articles

Integrated cell-free DNA and RNA sequencing recapitulates bone marrow genomic and transcriptomic alterations in multiple myeloma

Free
Alexander Pentakalos, David Coffey, Tomas Jelinek, Katie Thoren, Elizabeth Lyubchenko, Stephanie Fernandes, Bahar Bahrani Fard, Dickran Kazandjian, James Hoffman, Benjamin Diamond, Abhishek Pandey, Marcella Kaddoura, Brian Walker, Stephanie Mompoint, Kellye Koubek, Sindy Gutierrez, Caterine Diaz, Yahirini Martinez, Faika Shah, Suzan Rosen, Wilson Garcia, Yosmira Dominguez, Michelle Armogan, Frank Kuhr, Wojciech Swat, Maher Albitar, Ola Landgren
Journal: Blood
Blood (2025) 146 (Supplement 1): 7483.
https://doi.org/10.1182/blood-2025-7483
Published: 2025
Journal Articles

Standardizing lines of treatment (LOT) in multiple myeloma: Real-world validation of an automated rule-based algorithm

Free
Patricia Alejandra Flores Pérez, Juan Pablo Capdevila, Karla Mariana Castro Bórquez, Samuel Bennion, Jay Hydren, Giovanni Galbuchi, Rachel Jensen, Mason Barnes, Jael Antonio Liñán Esparza, Felipe Flores Quiroz, Jennifer Ahlstrom, Daniel Auclair, Rahul Banerjee, Ola Landgren, David Coffey, Nadine Abdallah, Urvi Shah, Peter Voorhees, Douglas Sborov, Malin Hultcrantz, Jorge Arturo Hurtado Martinez
Journal: Blood
Blood (2025) 146 (Supplement 1): 8154.
https://doi.org/10.1182/blood-2025-8154
Published: 2025
Journal Articles

Final results of a multi-center phase 2 trial of isatuximab-lenalidomide in patients with high risk smoldering multiple myeloma (HRSMM)

Free
Sheeba Thomas, Elisabet Manasanch, Sundar Jagannath, Neha Korde, Hans Lee, David Berrios, Krina Patel, Swami Iyer, Sham Mailankody, Behrang Amini, Pei Lin, Zuzana Berkova, Donna Weber, Gregory Kaufman, Lei Feng, Michelle Hildebrandt, Linghua Wang, Sattva Neelapu, Robert Orlowski, Ola Landgren
Journal: Blood
Blood (2025) 146 (Supplement 1): 5834.
https://doi.org/10.1182/blood-2025-5834
Published: 2025
Journal Articles

Replacing FISH with a comprehensive integrated approach for tumor genotyping and immune monitoring in multiple myeloma: The flagship study

Free
David Coffey, Mark Meerson, Mainak Bardhan, Elizabeth Lyubchenko, Stephanie Fernandes, Dickran Kazandjian, James Hoffman, Benjamin Diamond, Abhishek Pandey, Marcella Kaddoura, Brian Walker, Stephanie Mompoint, Kellye Koubek, Sindy Gutierrez, Caterine Diaz, Yahirini Martinez, Faika Shah, Suzan Rosen, Wilson Garcia, Yosmira Dominguez, Michelle Armogan, Julia Alesse, Mary Abdou, Lizzie Sheehan, Daria Shavronskaya, Diana Lupova, Michael Goldberg, Ola Landgren
Journal: Blood
Blood (2025) 146 (Supplement 1): 7479.
https://doi.org/10.1182/blood-2025-7479
Published: 2025
Journal Articles

A phase 2 trial of iberdomide, carfilzomib, daratumumab and dexamethasone quadruplet therapy for relapsed/refractory multiple myeloma: The rekindle study

Free
Ola Landgren, James Hoffman, Abhishek Pandey, Andrew Kowalski, Michael Durante, David Coffey, Marcella Kaddoura, Brian Walker, Leslie Gallardo, Elizabeth Lyubchenko, Massiel Cardo Lopez, Fiorela Flores, Liettel Ortega, Rabia Bukhari, Kellye Koubek, Caterine Diaz, Stephanie Mompoint, Sindy Gutierrez, Faika Shah, Stephanie Fernandes, Michelle Armogan, Dickran Kazandjian, Benjamin Diamond
Journal: Blood
Blood (2025) 146 (Supplement 1): 251.
https://doi.org/10.1182/blood-2025-251
Published: 2025
Journal Articles

A phase 2 trial of abbreviated fixed-duration (Default 4 Cycles) linvoseltamab immuno-consolidation to deepen responses post newly diagnosed multiple myeloma combination therapy for minimal residual disease positivity (the IMMUNOPLANT Study)

Free
Dickran Kazandjian, Benjamin Diamond, James Hoffman, Abhishek Pandey, David Coffey, Marcella Kaddoura, Brian Walker, David Lessen, Caterine Diaz, Stephanie Mompoint, Sindy Gutierrez, Jennifer Chapman, Yi Zhou, Mike Georgiou, Russ Kuker, Kellye Koubek, Andrew Kowalski, Leslie Gallardo, Stephanie Fernandes, Fiorela Flores, Rabia Bukhari, Sunwoo Han, Michelle Armogan, Ola Landgren
Journal: Blood
Blood (2025) 146 (Supplement 1): 248.
https://doi.org/10.1182/blood-2025-248
Published: 2025
Journal Articles

On the cellular origins of multiple myeloma

Free
Dennis Lee, Patrick Blaney, Reva Shenwai, Sanghoon Lee, Di Zhang, Marc Braunstein, David Kaminetzky, Lisa Cervia, Kern Hast, Timothy Chu, Lara Winterkorn, Benjamin Diamond, Neha Korde, Alexander Lesokhin, Elizabeth Brown, Nicolas Robine, Kylee Maclachlan, Francesco Maura, Saad Usmani, Ola Landgren, Brian Walker, Faith Davies, Iryna Berezniuk, Oscar Lahoud, Christopher Park, Gareth Morgan
Journal: Blood
Blood (2025) 146 (Supplement 1): 5694.
https://doi.org/10.1182/blood-2025-5694
Published: 2025
Journal Articles

Chromothripsis drives high-risk multiple myeloma by copy number abnormalities and rewiring the epigenome to activate oncogenic programs.

Free
Enze Liu, Nathan Becker, Sreejeta Mondal, Attaya Suvannasankha, David Coffey, Benjamin Diamond, Abhishek Pandey, Kelvin Lee, Dickran Kazandjian, Rafat Abonour, Aneta Mikulasova, Gareth Morgan, Ola Landgren, Brian Walker
Journal: Blood
Blood (2025) 146 (Supplement 1): 5693.
https://doi.org/10.1182/blood-2025-5693
Published: 2025
Journal Articles

High-dimensional profiling reveals predominant depletion of NK cell effector phenotypes in relapsed/refractory multiple myeloma patients treated with anti-CD38 therapy

Free
Ondrej Venglar, Daniel Bilek, Eva Radova, Veronika Kapustova, Marketa Kudelkova, Lucie Broskevicova, Karina Merendova, Jan Vrana, Tereza Popkova, Ludmila Muronova, Jana Mihalyova, Michael Durante, Juli Bago, Benjamin Diamond, Michal Simicek, Brian Walker, Tereza Sevcikova, David Žihala, Ola Landgren, Roman Hajek, Tomas Jelinek
Journal: Blood
Blood (2025) 146 (Supplement 1): 5720.
https://doi.org/10.1182/blood-2025-5720
Published: 2025
Journal Articles

Multiomic evidence of coordinated complex rearrangements, enhancer hijacking, and epigenomic signatures in the first whole-chromosome-phased myeloma genomes

Free
Nathan Becker, Enze Liu, Zackary Sanborn, Attaya Suvannasankha, Kelvin Lee, Dickran Kazandjian, James Hoffman, Benjamin Diamond, Abhishek Pandey, Rafat Abonour, Ola Landgren, Lisa Munding, Aneta Mikulasova, Brian Walker
Journal: Blood
Blood (2025) 146 (Supplement 1): 3928.
https://doi.org/10.1182/blood-2025-3928
Published: 2025
Journal Articles

Biology of circulating tumor cells (CTCs) in multiple myeloma (MM): Comparative transcriptomic profiling reveals egression-associated changes related to CTC burden

Free
Daniel Bilek, Eva Radova, Veronika Kapustova, Ondrej Venglar, Serafim Nenarokov, Lucie Broskevicova, Jan Vrana, Marketa Kudelkova, Ludmila Muronova, Tereza Popkova, Jana Mihalyova, Hana Plonkova, Michael Durante, Benjamin Diamond, Michal Simicek, Juli Bago, David Žihala, Tereza Sevcikova, Ola Landgren, Roman Hajek, Tomas Jelinek
Journal: Blood
Blood (2025) 146 (Supplement 1): 3927.
https://doi.org/10.1182/blood-2025-3927
Published: 2025
Journal Articles

Disease burden by NGS in bone marrow and peripheral blood samples at baseline and after frontline therapy: Subgroup analysis of the advance randomized multi-center study of carfilzomib, lenalidomide and dexamethasone (KRd) with or without daratumumab (D) in patients with newly diagnosed multiple myeloma (NDMM)

Free
Michael Durante, J Christine Ye, Jens Hillengass, Douglas Sborov, James Hoffman, Benjamin Diamond, David Coffey, Marcella Kaddoura, Abhishek Pandey, Kellye Koubek, Stephanie Mompoint, Sindy Gutierrez, Caterine Diaz, Michelle Armogan, Rachid Baz, Robert Orlowski, Thomas Jandl, Neha Korde, Heidi Simmons, Allison Jacob, Kenneth Shain, Dickran Kazandjian, Ola Landgren
Journal: Blood
Blood (2025) 146 (Supplement 1): 7454.
https://doi.org/10.1182/blood-2025-7454
Published: 2025
Journal Articles

Cytogenetic subgroup analysis of the advance trial: A randomized multi-center study of carfilzomib, lenalidomide and dexamethasone (KRd) with or without daratumumab (D) in patients with newly diagnosed multiple myeloma (NDMM)

Free
Michael Durante, J Christine Ye, Jens Hillengass, Douglas Sborov, James Hoffman, Benjamin Diamond, David Coffey, Marcella Kaddoura, Abhishek Pandey, Kellye Koubek, Stephanie Mompoint, Sindy Gutierrez, Caterine Diaz, Michelle Armogan, Rachid Baz, Robert Orlowski, Thomas Jandl, Neha Korde, Kenneth Shain, Dickran Kazandjian, Ola Landgren
Journal: Blood
Blood (2025) 146 (Supplement 1): 5763.
https://doi.org/10.1182/blood-2025-5763
Published: 2025
Journal Articles

Whole genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma

Free
Chrissy Baker, Elizabeth Hill, Dickran Kazandjian, Marios Papadimitriou, Michael Durante, Abhishek Pandey, Bachisio Ziccheddu, Tomas Jelinek, David Coffey, Brian Walker, Ryan Young, Kylee Maclachlan, Neha Korde, Nickoli Parkinson, Zoe Goldstein, Alexi Runnels, William Hooper, Nicolas Robine, Dan Avi Landau, Francesco Maura, Ola Landgren, Benjamin Diamond
Journal: Blood
Blood (2025) 146 (Supplement 1): 3920.
https://doi.org/10.1182/blood-2025-3920
Published: 2025
Journal Articles

Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma – final results from a randomized investigator-initiated trial

Free
Sridevi Rajeeve, Andriy Derkach, Sean Devlin, Jeannen Santos, Anna Przemielewska, Tara Sood, Francesca Castro, Thomas Atkinson, Kylee Maclachlan, Hamza Hashmi, Carlyn Tan, Neha Korde, Malin Hultcrantz, Alexander Lesokhin, Hani Hassoun, Parastoo Dahi, Michael Scordo, David Chung, Heather Landau, Gunjan Shah, Ola Landgren, Sergio Giralt, Sham Mailankody, Saad Usmani, Urvi Shah
Journal: Blood
Blood (2025) 146 (Supplement 1): 2273.
https://doi.org/10.1182/blood-2025-2273
Published: 2025
Journal Articles

Monoclonal gammopathy-related coagulopathies: A systematic analysis

Free
Tessa Lavorgna, Thomas Plate, Diana Byrnes, Dickran Kazandjian, Benjamin Diamond, James Hoffman, Ola Landgren, Gerald Soff
Journal: Blood
Blood (2025) 146 (Supplement 1): 1305.
https://doi.org/10.1182/blood-2025-1305
Published: 2025
Journal Articles

Adherence to the 2018 world cancer research fund/American institute for cancer research cancer prevention recommendations and mortality among blood cancer survivors

Free
LaShae Rolle, Harleen Kaur, Melissa Lopez-Pentecost, Coral Levkovitz, Abhishek Pandey, Ola Landgren, Craig Moskowitz, Tracy Crane
Journal: Blood
Blood (2025) 146 (Supplement 1): 4538.
https://doi.org/10.1182/blood-2025-4538
Published: 2025